Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2012 Publisher: Boehringer Ingelheim Limited Ellesfield Avenue Bracknell Berkshire RG12 8YS United Kingdom
PERSANTIN Tablets 100 mg.
| Pharmaceutical Form |
|---|
|
Coated Tablets. Round, white, biconvex, shiny, sugar-coated tablets. |
Dipyridamole 100 mg.
For excipients, see 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Dipyridamole |
Dipyridamole is an antithrombotic agent with antiplatelet activity. Dipyridamole has an antithrombotic action based on its ability to modify various aspects of platelet function, such as platelet aggregation, adhesion and survival, which are factors associated with the initiation of thrombus formation. |
| List of Excipients |
|---|
|
Core: Calcium hydrogen phosphate, anhydrous Coating: Sucrose |
Marketed packs: Blister pack containing 84 white sugar coated tablets
Non-marketed packs: Blister packs of 100 and 112 white sugar coated tablets.
Boehringer Ingelheim Limited
Ellesfield Avenue
Bracknell
Berkshire
RG12 8YS
United Kingdom
PL 0015/5016R
24 November 1988 / 01 May 2007
| Drug | Countries | |
|---|---|---|
| PERSANTIN | Austria, Brazil, Cyprus, Spain, Finland, Hong Kong, Croatia, Japan, Mexico, Netherlands, Singapore, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
